0001453687-19-000168.txt : 20191203 0001453687-19-000168.hdr.sgml : 20191203 20191203162001 ACCESSION NUMBER: 0001453687-19-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191201 FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brunn Carsten CENTRAL INDEX KEY: 0001760229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37798 FILM NUMBER: 191266014 MAIL ADDRESS: STREET 1: C/O SELECTA BIOSCIENCES, INC. STREET 2: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC CENTRAL INDEX KEY: 0001453687 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-923-1400 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 wf-form4_157540798248948.xml FORM 4 X0306 4 2019-12-01 0 0001453687 SELECTA BIOSCIENCES INC SELB 0001760229 Brunn Carsten C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL WAY WATERTOWN MA 02472 1 1 0 0 President and CEO Common Stock 2019-12-01 4 M 0 43750 0 A 85186 D Common Stock 2019-12-02 4 S 0 14272 1.5281 D 70914 D Restricted Stock Units 2019-12-01 4 M 0 43750 0 D Common Stock 43750.0 131250 D Each restricted stock unit represents a contingent right to receive one share of common stock. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.50 to $1.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These restricted stock units vested as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date. /s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn 2019-12-03